Przuntek H - Search Results

1

Interventional Influence of the Intestinal Microbiome Through Dietary Intervention and Bowel Cleansing Might Improve Motor Symptoms in Parkinson's Disease.

Hegelmaier T, Lebbing M, Duscha A, Tomaske L, Tönges L, Holm JB, Bjørn Nielsen H, Gatermann SG, Przuntek H, Haghikia A. Hegelmaier T, et al. Among authors: przuntek h. Cells. 2020 Feb 6;9(2):376. doi: 10.3390/cells9020376. Cells. 2020. PMID: 32041265 Free PMC article. Clinical Trial.

2

Propionic Acid Shapes the Multiple Sclerosis Disease Course by an Immunomodulatory Mechanism.

Duscha A, Gisevius B, Hirschberg S, Yissachar N, Stangl GI, Dawin E, Bader V, Haase S, Kaisler J, David C, Schneider R, Troisi R, Zent D, Hegelmaier T, Dokalis N, Gerstein S, Del Mare-Roumani S, Amidror S, Staszewski O, Poschmann G, Stühler K, Hirche F, Balogh A, Kempa S, Träger P, Zaiss MM, Holm JB, Massa MG, Nielsen HB, Faissner A, Lukas C, Gatermann SG, Scholz M, Przuntek H, Prinz M, Forslund SK, Winklhofer KF, Müller DN, Linker RA, Gold R, Haghikia A. Duscha A, et al. Among authors: przuntek h. Cell. 2020 Mar 19;180(6):1067-1080.e16. doi: 10.1016/j.cell.2020.02.035. Epub 2020 Mar 10. Cell. 2020. PMID: 32160527 Free article.

3

Clinical effects of repetitive transcranial magnetic stimulation versus acute levodopa challenge in Parkinson's disease.

Börnke Ch, Schulte T, Przuntek H, Müller T. Börnke Ch, et al. Among authors: przuntek h. J Neural Transm Suppl. 2004;(68):61-7. doi: 10.1007/978-3-7091-0579-5_7. J Neural Transm Suppl. 2004. PMID: 15354390 Clinical Trial.

4

L-Dopa improves colour vision in Parkinson's disease.

Büttner T, Kuhn W, Patzold T, Przuntek H. Büttner T, et al. Among authors: przuntek h. J Neural Transm Park Dis Dement Sect. 1994;7(1):13-9. doi: 10.1007/BF02252659. J Neural Transm Park Dis Dement Sect. 1994. PMID: 8579766 Clinical Trial.

5

Color vision in Parkinson's disease: missing influence of amantadine sulphate.

Büttner T, Kuhn W, Müller T, Patzold T, Przuntek H. Büttner T, et al. Among authors: przuntek h. Clin Neuropharmacol. 1995 Oct;18(5):458-63. doi: 10.1097/00002826-199510000-00009. Clin Neuropharmacol. 1995. PMID: 8665560

6

Non-dopaminergic therapy in Parkinson's disease.

Przuntek H. Przuntek H. J Neurol. 2000 Apr;247 Suppl 2:II19-24. doi: 10.1007/pl00007756. J Neurol. 2000. PMID: 10991661 Review.

7

Assessment of symptoms of Parkinson's disease by apparative methods.

Kraus PH, Klotz P, Fischer A, Przuntek H. Kraus PH, et al. Among authors: przuntek h. J Neural Transm Suppl. 1987;25:89-96. J Neural Transm Suppl. 1987. PMID: 3480941

8

Analysis of the course of Parkinson's disease under dopaminergic therapy: performance of "fast tapping" is not a suitable parameter.

Kraus PH, Klotz P, Hoffmann A, Lewe J, Przuntek H. Kraus PH, et al. Among authors: przuntek h. Mov Disord. 2005 Mar;20(3):348-54. doi: 10.1002/mds.20265. Mov Disord. 2005. PMID: 15584027

9

Elevated plasma levels of homocysteine in Parkinson's disease.

Kuhn W, Roebroek R, Blom H, van Oppenraaij D, Przuntek H, Kretschmer A, Büttner T, Woitalla D, Müller T. Kuhn W, et al. Among authors: przuntek h. Eur Neurol. 1998 Nov;40(4):225-7. doi: 10.1159/000007984. Eur Neurol. 1998. PMID: 9813406

10

Long-term observation of chronic subcutaneous administration of lisuride in the treatment of motor fluctuations in Parkinson's disease.

Heinz A, Suchy I, Klewin I, Kuhn W, Klotz P, Przuntek H. Heinz A, et al. Among authors: przuntek h. J Neural Transm Park Dis Dement Sect. 1992;4:291-301. doi: 10.1007/BF02260078. J Neural Transm Park Dis Dement Sect. 1992. PMID: 1388700

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

307 results

Search Page